Biocatalytic chemical processes enabled by Codexis’ proprietary directed evolution platform technology create significant value for our partners. Codexis has a proprietary and disruptive technology platform which produces proprietary biocatalysts Close
Biocatalyst or Biological CatalystA catalyst derived from a living organism. Enzymes and fermentation strains are common biocatalysts. Biocatalysts significantly speed chemical reactions.addressing multiple major target markets. This platform has been validated through partnerships with global industry leaders in pharmaceuticals and bioindustrials. The company has a capital-efficient business model and a diversified and visible revenue base. Read more about the Codexis competitive advantage.
- Proprietary and Disruptive Technology Platform
- Multiple Major Target Markets
- Partnerships with Global Industry Leaders
- Capital-Efficient Business Model
- Diversified and Visible Revenue Base
Proprietary and Disruptive Technology Platform
The Codexis proprietary technology addresses the significant limitations of current approaches used to develop biocatalysts and ultimately enables biocatalytic-based processes that have substantial advantages over conventional chemistry. The platform allows the company to quickly develop biocatalysts suitable for commercial scale and enables development of biocatalysts with improved performance characteristics rarely present in naturally-occurring biocatalysts. Codexis believes its technology platform can enable products now impossible to produce economically at commercial scale.
Multiple Major Target Markets
Codexis produces biocatalysts used at commercial scale in both the generic and innovator pharmaceutical markets. Codexis is also working with Shell to develop biocatalysts for use in producing biofuels CloseBiofuelsFuels derived from biomass. Biofuels are a renewable energy source. Alcohols such as ethanol and butanol are sometimes called bioethanol and biobutanol when they are derived from biomass. from cellulosic biomass CloseBiomassAny living or recently living biological material that can be used to produce fuel. Most often, biomass refers to plant matter that is grown for biofuels. Biomass can be grown sources including switch grass, hemp, willow, corn and sugarcane plants.sources. Other bioindustrial markets of interest include carbon management, water treatment and chemicals.
Partnerships with Global Industry Leaders
The Codexis technology platform has been validated through delivery of drug manufacturing processes or products to numerous leading pharmaceutical companies, including Merck, Pfizer, Schering-Plough and Arch and in biofuels through a research collaboration with Shell. This partnership began with a one-year research agreement in 2006, in which Codexis exceeded targets related to enzyme CloseEnzymeProteins that act as catalysts, or biocatalysts, in living organisms.performance, and was extended to a new, five-year research collaboration in 2007.
Capital-Efficient Business Model
The company’s business model leverages Codexis collaborators’ engineering, manufacturing and commercial expertise, distribution infrastructure and ability to fund commercial scale production facilities. As collaborators choose to use Codexis technology to commercialize new products, the company believes that this capital-efficient business model will allow Codexis to expand into new markets without having to finance or operate large industrial facilities.
Diversified and Visible Revenue Base
The Codexis revenue stream is diversified across various industries, with revenues derived from the innovator and generic pharmaceuticals markets and biofuels development. The company intends to further diversify its revenue by pursuing funded collaborations in other bioindustrial markets, such as carbon management, water treatment and chemicals.